BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15622459)

  • 21. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
    Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-stage of non-small cell lung cancer directly invading an adjacent lobe.
    Haam SJ; Park IK; Paik HC; Kim DJ; Lee DY; Lee JG; Bae MK; Chung KY
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):807-10; discussion 810-1. PubMed ID: 22723615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
    Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vascular invasion by tumor in the absence of regional lymph node metastases in patients with locally advanced non-small cell lung cancer].
    Akopov AL; Dvorakovskaia IV
    Vopr Onkol; 2004; 50(4):417-20. PubMed ID: 15605763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and surgical treatment for stage I non-small-cell lung cancer].
    Gao YS; Zhang DC; He J; Sun KL; Zhang DW; Zhang RG
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):52-5. PubMed ID: 15771801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer.
    Suemitsu R; Yoshino I; Tomiyasu M; Fukuyama S; Okamoto T; Maehara Y
    Surg Today; 2004; 34(11):896-901. PubMed ID: 15526122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The stratification of surgically treated T4 (stage IIIb) primary lung cancers; analysis of cases with intrapulmonary metastases in the same lobe as the primary tumors (pm 1) and invading adjacent organs].
    Harada H; Nishio W; Sakamoto T; Uchino K; Matsuoka H; Tsubota N
    Kyobu Geka; 2003 Jul; 56(7):541-4. PubMed ID: 12854459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
    Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
    Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):87-93. PubMed ID: 15632829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node mapping and molecular staging in nonsmall cell lung carcinoma.
    Pulte D; Li E; Crawford BK; Newman E; Alexander A; Mustalish DC; Jacobson DR
    Cancer; 2005 Oct; 104(7):1453-61. PubMed ID: 16130135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
    Mansour Z; Kochetkova EA; Santelmo N; Ducrocq X; Quoix E; Wihlm JM; Massard G
    Ann Thorac Surg; 2008 Jul; 86(1):228-33. PubMed ID: 18573428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of pleural lavage cytology for non-small cell lung cancer: is surgical resection valid for patients with positive pleural lavage cytology?
    Kawachi R; Nakazato Y; Masui K; Takei H; Koshi-ishi Y; Goya T
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):265-8. PubMed ID: 19429636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term results following resection for T3 non-small cell lung cancer].
    Maniwa Y; Okada M; Yamamoto H
    Kyobu Geka; 1998 Oct; 51(11):939-43. PubMed ID: 9789424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognosis of T3 patients with resected non-small cell lung cancer according to the invaded organs].
    Inoue K; Sagawa M; Sato M; Ono S; Matsumura T; Sakurada A; Handa M; Tanita T; Kondo T; Fujimura S
    Kyobu Geka; 1998 Oct; 51(11):907-10. PubMed ID: 9789417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome following lung resections for pT1 non-small cell lung cancer.
    Kopp R; Weidenhagen R; Reinmiedl J; Müller C; Fürst H; Bittmann I; Dienemann H; Hatz R
    Eur J Surg Oncol; 2006 Apr; 32(3):329-34. PubMed ID: 16414234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of surgical treatment for non-small cell lung cancer of 20 mm or less in diameter.
    Iwasaki A; Shirakusa T; Yoneda S; Makimoto Y; Enatsu S; Hamada T
    Thorac Cardiovasc Surg; 2004 Oct; 52(5):293-7. PubMed ID: 15470611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.